Regulation of DARPP-32 phosphorylation by Δ9-tetrahydrocannabinol (Q56504097)

No description defined

Language	Label	Description	Also known as
English	Regulation of DARPP-32 phosphorylation by Δ9-tetrahydrocannabinol	No description defined

Statements

instance of

scholarly article

0 references

title

Regulation of DARPP-32 phosphorylation by Δ9-tetrahydrocannabinol (English)

0 references

0 references

0 references

0 references

Daniel Marcellino

2

0 references

Paul Greengard

object named as

Paul Greengard

series ordinal

4

0 references

Kjell Fuxe

object named as

Kjell Fuxe

series ordinal

3

0 references

author name string

Anders Borgkvist

series ordinal

1

0 references

Gilberto Fisone

series ordinal

5

0 references

publication date

January 2008

0 references

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Neuropharmacology

0 references

volume

54

0 references

issue

1

0 references

page(s)

31-35

0 references

cites work

The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Motor actions of cannabinoids in the basal ganglia output nuclei

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Endocannabinoid-mediated short-term suppression of excitatory synaptic transmission to medium spiny neurons in the striatum

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Erratum: Activation of the cAMP/PKA/DARPP-32 Signaling Pathway is Required for Morphine Psychomotor Stimulation but not for Morphine Reward

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Phosphorylation of DARPP-32 is regulated by GABA in rat striatum and substantia nigra

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

DARPP-32: regulator of the efficacy of dopaminergic neurotransmission

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.NEUROPHARM.2007.06.025

Identifiers

DOI

10.1016/J.NEUROPHARM.2007.06.025

0 references

PubMed ID

17686497

0 references

Regulation of DARPP-32 phosphorylation by Δ9-tetrahydrocannabinol (Q56504097)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Regulation of DARPP-32 phosphorylation by Δ9-tetrahydrocannabinol (Q56504097)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search